Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, announced its participation in the American Society of Gene and Cell ...

Stay up to date on the latest science with Brush Up Summaries. “Molecular farming started out with transgenic plants,” said Rybicki. Scientists developed several strategies to produce transgenic ...

Mammalian cell systems, chiefly Chinese hamster ovary (CHO) and human embryonic kidney (HEK293) lines, constitute the principal platforms for the manufacture of therapeutic proteins. Their capacity to ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful commissioning of another ...

For decades, Chinese hamster ovary (CHO) cells have been the gold standard for producing biologic drugs, from monoclonal ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The recombinant cell culture supplements market is set to grow due to rising biologics demand and advances in gene therapy.